FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013171330> ?p ?o ?g. }

• W2013171330 endingPage "211" @default.
• W2013171330 startingPage "207" @default.
• W2013171330 abstract "Nearly 40% of children treated within the AML BFM studies experience recurrence of their disease after having achieved remission. In our retrospective analysis we tried to estimate prognosis after relapse in children treated with intensive relapse regimens and studied the impact of prognostic factors for second remission and survival.102 patients suffering from first relapse were treated intensively according to the relapse protocols BFM REZ91 and REZ93 or intensive salvage therapy consisting of double induction with high dose Ara-C, mitoxantrone and VP-16. Once in CR, patients continued to receive a 6-week consolidation and either allogeneic or autologous bone marrow transplantation (BMT).Time to relapse was in median 1.1 years, range 0-8 years. Fifty-two of 102 pts. (51%) achieved 2nd remission (CR), 10 (10%) partial remission, 37 (36%) were nonresponders, and 3(3%) died early during salvage therapy. Twenty-seven were still in CR, median 2.5 years, range 0.4-7.0 years, with an overall survival of 21%, SE 5% after 5 years. The response and survival rate was similar in all treatment groups. Fifty patients were transplanted, 43 being in 2nd CR, and 7 with residual blasts. Twenty-seven patients received an allograft: Twenty-one from a matched sibling (MSD), 1 from a haploid and 5 from a matched unrelated donor (MUD); 23 received an autograft. None of the patients transplanted in partial remission survived. Whereas 7 of 16 patients were alive after MSD in 2nd CR, 1 after haploid BMT. Four of 5 patients died after MUD BMT. Multivariate risk factor analysis revealed duration until relapse to be the most important factor for survival after relapse. The maximum risk-ratio was obtained at a threshold value of 1.5 years after diagnosis resulting in a 5-year survival of 10%, SE 5% for early relapse, and 40%, SE 10% for late relapse, p logrank 0.0001.Intensive relapse regimens can induce a 2nd CR in half of the patients. Children with late relapse (> 1.5 years after diagnosis) have a realistic chance for longtime survival." @default.
• W2013171330 created "2016-06-24" @default.
• W2013171330 creator A5003366137 @default.
• W2013171330 creator A5031643099 @default.
• W2013171330 creator A5037725633 @default.
• W2013171330 creator A5039494827 @default.
• W2013171330 creator A5044138253 @default.
• W2013171330 creator A5059512316 @default.
• W2013171330 date "1998-07-01" @default.
• W2013171330 modified "2023-10-14" @default.
• W2013171330 title "Prognose von Kindern mit AML nach dem ersten Rezidiv" @default.
• W2013171330 doi "https://doi.org/10.1055/s-2008-1043880" @default.
• W2013171330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9743954" @default.
• W2013171330 hasPublicationYear "1998" @default.
• W2013171330 type Work @default.
• W2013171330 sameAs 2013171330 @default.
• W2013171330 citedByCount "3" @default.
• W2013171330 countsByYear W20131713302015 @default.
• W2013171330 countsByYear W20131713302020 @default.
• W2013171330 crossrefType "journal-article" @default.
• W2013171330 hasAuthorship W2013171330A5003366137 @default.
• W2013171330 hasAuthorship W2013171330A5031643099 @default.
• W2013171330 hasAuthorship W2013171330A5037725633 @default.
• W2013171330 hasAuthorship W2013171330A5039494827 @default.
• W2013171330 hasAuthorship W2013171330A5044138253 @default.
• W2013171330 hasAuthorship W2013171330A5059512316 @default.
• W2013171330 hasConcept C126322002 @default.
• W2013171330 hasConcept C141071460 @default.
• W2013171330 hasConcept C167135981 @default.
• W2013171330 hasConcept C2776694085 @default.
• W2013171330 hasConcept C2780775027 @default.
• W2013171330 hasConcept C2780923524 @default.
• W2013171330 hasConcept C3018657049 @default.
• W2013171330 hasConcept C71924100 @default.
• W2013171330 hasConceptScore W2013171330C126322002 @default.
• W2013171330 hasConceptScore W2013171330C141071460 @default.
• W2013171330 hasConceptScore W2013171330C167135981 @default.
• W2013171330 hasConceptScore W2013171330C2776694085 @default.
• W2013171330 hasConceptScore W2013171330C2780775027 @default.
• W2013171330 hasConceptScore W2013171330C2780923524 @default.
• W2013171330 hasConceptScore W2013171330C3018657049 @default.
• W2013171330 hasConceptScore W2013171330C71924100 @default.
• W2013171330 hasIssue "04" @default.
• W2013171330 hasLocation W20131713301 @default.
• W2013171330 hasLocation W20131713302 @default.
• W2013171330 hasOpenAccess W2013171330 @default.
• W2013171330 hasPrimaryLocation W20131713301 @default.
• W2013171330 hasRelatedWork W129395767 @default.
• W2013171330 hasRelatedWork W2003938723 @default.
• W2013171330 hasRelatedWork W2013171330 @default.
• W2013171330 hasRelatedWork W2047967234 @default.
• W2013171330 hasRelatedWork W2064930805 @default.
• W2013171330 hasRelatedWork W2118496982 @default.
• W2013171330 hasRelatedWork W2407638792 @default.
• W2013171330 hasRelatedWork W2439875401 @default.
• W2013171330 hasRelatedWork W4302594281 @default.
• W2013171330 hasRelatedWork W2525756941 @default.
• W2013171330 hasVolume "210" @default.
• W2013171330 isParatext "false" @default.
• W2013171330 isRetracted "false" @default.
• W2013171330 magId "2013171330" @default.
• W2013171330 workType "article" @default.